中国P站

Mitochondrial dysfunction; Neurotoxicity; Oxidative stress; Neurodegeneration; Experimental models; Reactive oxygen species; ATP depletion; Calcium homeostasis; Mitochondrial membrane potential; Neuronal injury; Mitochondrial biogenesis; Apoptosis; Neuroinflammation; Mitochondrial permeability transition pore; Metabolic impairment

Introduction

Mitochondria are essential organelles responsible for energy production, redox balance, and the regulation of cell death pathways. In the central nervous system (CNS), their role is especially critical due to the high metabolic demand of neurons and their reliance on oxidative phosphorylation for ATP generation. Mitochondrial dysfunction has been implicated in various neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis. Experimental neurotoxicity models provide critical insights into the cellular and biochemical cascades associated with mitochondrial impairment in neuronal populations. This article explores the biochemical basis of mitochondrial dysfunction in experimental neurotoxicity, emphasizing key mechanisms such as oxidative stress, ATP depletion, calcium dyshomeostasis, and activation of cell death pathways [1].

Description

Experimental neurotoxicity refers to laboratory-based studies aimed at understanding the cellular and molecular effects of toxic substances on the nervous system. Neurotoxic agents such as rotenone, MPTP, 6-hydroxydopamine (6-OHDA), and glutamate have been extensively used to replicate features of mitochondrial dysfunction observed in human neurodegenerative diseases. These substances exert their deleterious effects through various biochemical mechanisms, including inhibition of electron transport chain (ETC) complexes, induction of reactive oxygen species (ROS), and disruption of mitochondrial dynamics [2].

A central feature of mitochondrial dysfunction in neurotoxicity is impaired ATP synthesis. Mitochondria generate ATP primarily through oxidative phosphorylation, a process heavily dependent on the integrity of the ETC, particularly complexes I and III. Neurotoxins like rotenone and MPTP selectively inhibit complex I activity, leading to reduced ATP generation and increased electron leakage, which in turn generates ROS. This energy deficit is particularly detrimental to neurons due to their limited glycolytic capacity and dependence on oxidative metabolism [3].

Another hallmark of mitochondrial dysfunction is oxidative stress. ROS are natural byproducts of mitochondrial respiration, but excessive production due to ETC impairment or antioxidant depletion can damage lipids, proteins, and DNA. Lipid peroxidation alters membrane fluidity and function, while protein carbonylation and nitration interfere with enzymatic activity and structural integrity. Mitochondrial DNA (mtDNA), lacking protective histones and efficient repair mechanisms, is particularly susceptible to oxidative damage, leading to further impairment of mitochondrial function and the propagation of a vicious cycle [4].

Calcium homeostasis is another critical aspect regulated by mitochondria. Under physiological conditions, mitochondria act as buffers for intracellular calcium, helping to modulate neurotransmitter release and synaptic plasticity. However, neurotoxic insults often lead to excessive calcium influx, overloading the mitochondrial matrix and triggering the opening of the mitochondrial permeability transition pore (mPTP). This non-specific channel collapses the mitochondrial membrane potential (ΔΨm), halts ATP production, and initiates the release of pro-apoptotic factors such as cytochrome c. Disruption of mitochondrial dynamics—namely fission, fusion, and mitophagy—also contributes to neuronal damage in neurotoxicity. Experimental models have demonstrated that neurotoxins can tilt the balance toward excessive mitochondrial fission, leading to fragmentation and isolation of damaged organelles. Inadequate mitophagy, the selective autophagic removal of dysfunctional mitochondria, further exacerbates cellular stress and promotes apoptotic cell death [5].

Discussion

The implications of mitochondrial dysfunction in experimental neurotoxicity are profound and multifaceted. From a biochemical perspective, the interplay between oxidative stress, energy metabolism, and apoptotic signaling defines the neurotoxic response. Experimental data support the notion that mitochondrial damage is not merely a consequence of neurotoxicity but often a primary driver of neuronal injury [6].

One of the most studied neurotoxic models is rotenone-induced Parkinsonism. Rotenone, a lipophilic pesticide, easily crosses the blood-brain barrier and selectively inhibits complex I of the ETC. Chronic exposure in animal models replicates key features of Parkinson’s disease, including dopaminergic neuronal loss in the substantia nigra, Lewy body formation, and motor deficits. Biochemically, rotenone exposure leads to ATP depletion, ROS generation, and activation of the intrinsic apoptotic pathway via cytochrome c release and caspase-9 activation. These models have helped elucidate mitochondrial dysfunction as a central mechanism in Parkinson’s pathogenesis [7].

Similarly, the excitotoxic effects of glutamate in neurotoxicity are mediated through mitochondrial pathways. Excessive activation of NMDA receptors leads to sustained calcium influx and mitochondrial overload. This results in mitochondrial depolarization, opening of the mPTP, and activation of downstream apoptotic cascades. Calcium-induced ROS generation further amplifies mitochondrial damage, creating a feed-forward loop that accelerates neuronal demise. In experimental models of Alzheimer&rsquos disease, such as those induced by amyloid-β (Aβ) peptides, mitochondrial dysfunction is evident early in disease progression. Aβ accumulates within mitochondria, impairs complex IV activity, and promotes oxidative stress. Biochemical studies show that Aβ interaction with mitochondrial proteins like cyclophilin D enhances mPTP sensitivity and contributes to synaptic dysfunction and memory loss [8].

Another critical aspect of mitochondrial dysfunction in neurotoxicity is the regulation of apoptosis. Mitochondria serve as convergence points for intrinsic apoptotic signaling, integrating stress signals such as DNA damage, ER stress, and ROS. The release of cytochrome c from mitochondria initiates caspase-dependent apoptosis, while other mitochondrial factors like AIF (apoptosis-inducing factor) and EndoG mediate caspase-independent pathways. Experimental models show that neurotoxins induce mitochondrial outer membrane permeabilization (MOMP) through Bax/Bak activation, highlighting the importance of mitochondrial integrity in neuronal fate decisions. Beyond apoptosis, mitochondrial dysfunction also contributes to neuroinflammation. Damaged mitochondria release danger-associated molecular patterns (DAMPs), including mtDNA and cardiolipin, which activate pattern recognition receptors such as TLR9 and NLRP3 inflammasome. This leads to the production of pro-inflammatory cytokines, further damaging neurons and glia. Experimental studies using mitochondrial inhibitors in glial cells have shown enhanced inflammatory responses, suggesting that targeting mitochondrial health may modulate neuroinflammatory outcomes [9].

Emerging research also focuses on mitochondrial biogenesis and its role in counteracting neurotoxicity. The PGC-1α (peroxisome proliferator-activated receptor gamma coactivator 1-alpha) pathway regulates the transcription of mitochondrial genes and promotes antioxidant defenses. In experimental models, agents that upregulate PGC-1α expression restore mitochondrial function, reduce oxidative stress, and protect against neurotoxic damage. These findings point to mitochondrial biogenesis as a potential therapeutic target [10].

Conclusion

Mitochondrial dysfunction lies at the heart of experimental neurotoxicity, acting as both a mediator and amplifier of neuronal injury. Biochemically, the processes of oxidative stress, energy failure, calcium imbalance, and apoptotic signaling converge at the mitochondria, highlighting their centrality in maintaining neuronal health. Experimental models have been instrumental in elucidating these mechanisms and replicating features of human neurodegenerative diseases. As our understanding deepens, mitochondria have emerged not only as markers of neuronal damage but also as promising targets for neuroprotective interventions. Future research into mitochondrial dynamics, mitophagy, and biogenesis may offer novel strategies to mitigate the effects of neurotoxic insults and slow the progression of neurodegenerative disorders.

References

1. Mormann F, Kreuz T, Rieke C, Andrzejak RG, Kraskovet A, et al. (2005) Clin Neurophysiol 116: 569-587.

   , ,

2. Bandarabadi M, Rasekhi J, Teixeira CA, Karami MR, Dourado A (2015) Epilepsy Behav 46: 158-166.

   , ,

3. Valderrama M, Alvarado C, Nikolopoulos S, Martinerie J, Adam C, et al. (2012) Biomed Sign 7: 237-244.

   ,

4. Ramgopal S, Thome-Souza S, Jackson M, Kadish NE, Fernandez IS, et al. (2014) Epilepsy Behav 37: 291-307.

   , ,

5. Acharya UR, Vinitha Sree S, Swapna G, Martis RJ, Suri JS (2013) Knowledge-Based Syst 45: 147-165.

   ,

6. Vergara XC, Sevilla A, D'Souza SL, Ang YS, Schaniel C, et al. (2010) Nature 465: 808-812.

   , ,

7. Casimiro MC, Knollmann BC, Ebert SN, Vary JC, Greene AE, et al. (2001) Proc Natl Acad Sci USA 98: 2526-2531.

   , ,

8. Cho M, Joo M, Kim K, Wook Y, Lee S (2018) Biochem Biophys Res Commun

   ,

9. Palugan L, Cerea M, Cirilli M, Moutaharrik S, Maroni A, et al. (2021) Int J Pharm X 3

   , ,

10. Faheem AM, Abdelkader DH (2020) . Elsevier LTD 1.